Ethan Oxley

Ethan Oxley is a Research Fellow at the Australian Centre for Blood Diseases, Monash University. His research focuses on blood cancers and immunotherapeutic approaches, with particular emphasis on acute myeloid leukemia (AML) and T-cell acute lymphoblastic leukemia (T-ALL).

Dr. Oxley's research interests span multiple areas of cancer biology and therapy development:

• Mechanisms of leukemia pathogenesis and relapse
• Immunotherapeutic approaches for blood cancers
• Molecular signaling pathways in hematological malignancies
• Development of novel anticancer biologics
• Protein interaction analysis at single-molecule resolution
• Transcription factor networks in blood cancers

His publication record shows consistent productivity from 2019-2025 with high-impact papers in Nature Communications, Cell Reports, and Blood. His work demonstrates a progression from fundamental molecular mechanisms of leukemia to translational immunotherapeutic applications, with his most recent research focusing on spatial protein analysis and checkpoint immunomodulation.

Dr. Oxley serves as a Chief Investigator on the "FLEX immunotherapeutics" project (2022-2024), which aims to develop a new class of anticancer biologics. This collaborative project demonstrates his commitment to translating basic research findings into potential therapeutic applications for blood cancers.